文献速递肝胆胰外科

腹腔镜与开腹大范围肝切除治疗肝硬化肝细胞癌的倾向性评分匹配分析

Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
PubMed 文献 · Surg Endosc · 2017-07-19

该回顾性研究纳入103例肝硬化合并肝细胞癌行大范围肝切除患者,其中腹腔镜组36例、开腹组67例,经1:1倾向性评分匹配后每组32例。结果显示腹腔镜组手术时间和Pringle阻断时间显著更长,但腹水发生率显著低于开腹组,总体并发症及2年总生存和无病生存无显著差异。提示对 selected 肝硬化HCC患者,腹腔镜大范围肝切除安全可行。

要点

  • 腹腔镜大范围肝切除手术时间和Pringle阻断时间显著长于开腹组
  • 腹腔镜组术后腹水发生率显著低于开腹组(9.4% vs 31.3%)
  • 两组2年总生存和无病生存无显著差异

核心结论

  • 肝硬化HCC患者行腹腔镜大范围肝切除的术后并发症和肿瘤学结局与开腹手术相当。
  • 腹腔镜大范围肝切除可作为 selected 肝硬化HCC患者安全可行的替代选择。

研究设计与样本

  • 回顾性分析2015年1月至2017年1月行大范围肝切除的肝硬化HCC患者。
  • 共纳入103例,腹腔镜组36例(35.0%),开腹组67例(65.0%)。
  • 经1:1倾向性评分匹配后每组32例进行比较。

主要发现

  • 匹配后腹腔镜组手术时间中位255 min,开腹组200 min(p < 0.001)。
  • 匹配后腹腔镜组Pringle阻断时间中位50 min,开腹组30 min(p < 0.001)。
  • 两组失血量和输血需求相当。
  • 腹腔镜组腹水发生率9.4%,开腹组31.3%(p = 0.030)。
  • 两组2年总生存率85.7% vs 86.7%(p = 0.694),无病生存率72.9% vs 81.5%(p = 0.990)。

临床怎么用

  • 对 selected 肝硬化HCC患者,腹腔镜大范围肝切除可考虑作为开腹手术的替代方案。
  • 需注意腹腔镜组手术时间和肝门阻断时间更长,应优化术中操作。
  • 腹腔镜组术后腹水发生率更低,可能有利于肝硬化患者术后恢复。

局限性

  • 回顾性研究设计。
  • 样本量较小,匹配后每组仅32例。
  • 单中心研究,结论需外推验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic major hepatectomy (LMH) for hepatocellular carcinoma (HCC) in patients with cirrhosis remains controversial due to limited reports in the literature. This study analyzed the perioperative and oncological outcomes of LMH for HCC with cirrhosis compared with open major hepatectomy (OMH). METHODS: A retrospective analysis of patients with cirrhosis who underwent major hepatectomy for HCC between January 2015 and January 2017 was performed. Patients were divided into the LMH group and the OMH group. Short-term and oncological outcomes were compared before and after 1:1 propensity score matching (PSM). RESULTS: A total of 103 HCC patients who received major liver resection were enrolled. There were 36 (35.0%) patients in the LMH group and 67 (65.0%) patients in the OMH group. After 1:1 PSM, well-matched 32 patients in each group were evaluated. Significant differences were observed in operative time (median, 255 vs. 200 min, p < 0.001) and Pringle time (median, 50 vs. 30 min, p < 0.001) between two groups. The blood loss and transfusion requirement were comparable in two groups. The rate of overall postoperative complications did not differ between two groups, while the incidence of ascites in the LMH group was significantly less than OMH group (9.4 vs. 31.3%, p = 0.030). The oncological outcomes between the two groups were comparable with regard to 2-year overall survival (85.7 vs. 86.7%, p = 0.694) and disease-free survival (72.9 vs. 81.5%, p = 0.990), respectively. CONCLUSIONS: LMH for HCC patients with liver cirrhosis showed comparable results in terms of postoperative morbidity and oncological outcomes compared with traditional open procedure. LMH may serve as a safe and feasible alternative for selected HCC patients with cirrhosis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xu HW, Liu F, Li HY, et al. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis. Surg Endosc. 2017. PMID: 28726140. doi:10.1007/s00464-017-5727-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。